Shareholder Inquiry Transfer Plan of Shandong Keyuan Pharmaceutical Co., Ltd.

Securities Code: 301281

Securities Abbreviation: Keyuan Pharmaceutical

Announcement Number: 2026-049

Shandong Keyuan Pharmaceutical Co., Ltd. Shareholder Inquiry Transfer Plan

The shareholder Jinan Anfu Venture Capital Partnership (Limited Partnership) guarantees that the information provided to the company does not contain any false records, misleading statements, or major omissions, and assumes legal responsibility for its authenticity, accuracy, and completeness. The company and all members of the board of directors guarantee that the announcement content is consistent with the information provided by the information discloser.

Special Reminder:

1. The shareholders participating in the inquiry transfer before the initial public offering of Shandong Keyuan Pharmaceutical Co., Ltd. (hereinafter referred to as "Keyuan Pharmaceutical," "the Company," or "this Company") are Jinan Anfu Venture Capital Partnership (Limited Partnership) (hereinafter referred to as "the Transferor");
2. The total number of shares to be transferred by the Transferor is 5,310,000 shares, accounting for 4.90% of the current total share capital of the company;
3. This inquiry transfer will not be conducted through centralized bidding or block trading and does not constitute a reduction in holdings through the secondary market. The shares acquired through the inquiry transfer cannot be transferred within 6 months after acquisition;
4. The transferee of this inquiry transfer will be institutional investors with corresponding pricing capabilities and risk tolerance.

I. Information on the Shareholders Participating in the Transfer

(1) Name, Number of Shares Held, and Shareholding Ratio of the Transferor

The Transferor entrusts Industrial Securities Co., Ltd. (hereinafter referred to as "Industrial Securities" or "Organizing Broker") to organize the inquiry transfer of Keyuan Pharmaceutical's shares before the initial public offering (hereinafter referred to as "this Inquiry Transfer"). As of the date of this announcement, the number of shares held by the Transferor and the proportion of the total share capital of the company are as follows:

Note: As of the date of this announcement, the total share capital of the company is 108,290,000 shares, and the shareholding ratio is calculated accordingly.